Adolescent intermittent ethanol exposure decreases perineuronal nets in the hippocampus in a sex dependent manner: Modulation through pharmacological inhibition of RPTPβ/ζ

Adolescence is a critical period for brain maturation in which this organ undergoes critical plasticity mechanisms that increase its vulnerability to the effects of alcohol. Significantly, ethanol-induced disruption of hippocampal neurogenesis has been related to cognitive decline in adulthood. During adolescence, the maturation of perineuronal nets (PNNs), extracellular matrix structures highly affected by ethanol consumption, plays a fundamental role in neurogenesis and plasticity in the hippocampus. Receptor Protein Tyrosine Phosphatase (RPTP) β/ζ is a critical anchor point for PNNs on the cell surface. Using the adolescent intermittent access to ethanol (IAE) model, we previously showed that MY10, a small-molecule inhibitor of RPTPβ/ζ, reduces chronic ethanol consumption in adolescent male mice but not in females and prevents IAE-induced neurogenic loss in the male hippocampus. We have now tested if these effects of MY10 are related to sex-dependent modulatory actions on ethanol-induced effects in PNNs. Our findings suggest a complex interplay between alcohol exposure, neural structures, and sex-related differences in the modulation of PNNs and parvalbumin (PV)-positive cells in the hippocampus. In general, IAE increased the number of PV + cells in the female hippocampus and reduced PNNs intensity in different hippocampal regions, particularly in male mice. Notably, we found that pharmacological inhibition of RPTPβ/ζ with MY10 regulates ethanol-induced alterations of PNNs intensity, which correlates with the protection of hippocampal neurogenesis from ethanol neurotoxic effects and may be related to the capacity of MY10 to increase the gene expression of key components of PNNs.

Optimization of a 5-day fixed-time embryo transfer (FTET) protocol in heifers I. Manipulation of circulating progesterone through reutilization of intravaginal progesterone devices during FTET

The objectives of the present study were to: 1) compare the reproductive efficiency of embryo transfer (ET) recipients after synchronization of estrus or a 5-day synchronization of ovulation protocol for fixed time ET (FTET), and 2) determine the effect of reutilization of intravaginal P4 devices (CIDRs), up to four times, in a 5-day FTET protocol. In Experiment 1, 817 dairy heifers were assigned to one of three groups: PGF + estrus detection, 5-d FTET protocol with new (1.38 g P4) or 2nd use CIDR (previously used once for 5 d). Fresh in vitro produced embryos were transferred 7 ± 1 day after estrus (PGF + estrus) or GnRH (5-day FTET). Utilization rate (transferred/treated) was greater (P < 0.001) in heifers submitted to FTET compared to ET after estrus, however pregnancies per ET (P/ET) were not different (P > 0.10). As a result, pregnancy per treated (P/treated) recipient was greater (P < 0.05) in heifers in the 5-day FTET protocol. In Experiment 2, 40 dairy heifers without a corpus luteum (CL) were randomly allocated into one of four groups using new, 2nd use, 3rd use (previously used twice for 5 d/each), or 4th use (previously used thrice for 5 d/each) CIDRs. Circulating P4 was reduced (P < 0.01) with each reutilization. In Experiment 3, ovarian follicular dynamics were evaluated in 238 dairy heifers submitted to a 5-day protocol with either new, 2nd use, 3rd use or 4th use CIDRs at random stages of the estrous cycle. Prostaglandin F2α (PGF) was administered at CIDR removal and again 24 h later. Ovulation was induced by GnRH treatment 72 h after CIDR removal. Preovulatory follicle diameter increased (P < 0.001) progressively with increasing CIDR reutilization. Ovulation rate did not differ between treatments, however, interval from CIDR removal to ovulation decreased (P < 0.001) in heifers receiving 3rd and 4th use CIDRs compared to new or 2nd use. Finally, in Experiments 4 and 5, 1203 heifers submitted to a 5-day FTET protocol were randomly assigned to receive either a new CIDR, a 3rd use CIDR (Experiment 4) or a 4th use CIDR (Experiment 5). Despite the increase in CL volume on D5 in heifers treated with 3rd use (P = 0.03) or 4th use CIDRs (P < 0.01), there were no differences (P > 0.05) in utilization rate, P/ET, or P/treated. Thus, use of a 5-day FTET synchronization protocol improves reproductive efficiency by increasing recipient utilization, and reutilization of CIDRs up to four times in recipient dairy heifers does not compromise reproductive performance.

Quantifying the effects of mastitis on the reproductive performance of dairy cows: A meta-analysis

The objective of this study was to conduct a meta-analysis to quantitatively characterize the effects of mastitis on the reproductive performance of dairy cows as well as to identify factors that interact with this relationship. A total of 29 publications were identified that contributed 24, 41, 27, 38, and 13 trial results to the meta-analysis of how mastitis is related to time to first service (TFS), days open (DO), services per conception (SPC), pregnancies per insemination at first service (FSP/AI) and pregnancy loss (PL), respectively. The meta-analyses were conducted using multilevel linear mixed-effects models. Overall, high levels of heterogeneity were present and meta-regression models only explained a small amount of heterogeneity. Results suggest that cows with mastitis pre-first insemination experience, on average, an additional 13.29 d to first service [95% confidence interval (CI): 6.64, 19.95] when compared with cows with no mastitis in the same time period. Moreover, in relation to cows with no mastitis in the same time period, 22.34 additional DO (95% CI: 12.89, 31.79) were estimated, on average, for cows with clinical mastitis at pre-insemination leading to conception. Additionally, 32.41 added DO (95% CI: 20.58, 44.25) were estimated, on average, for cows with clinical mastitis at pre- or post-insemination leading to conception compared with cows with no mastitis in the same time period. Finally, 20.03 additional DO (95% CI: 3.11, 36.95) were estimated, on average, for cows with subclinical mastitis pre- or post-insemination leading to conception compared with cows with no mastitis in the same time period. Effect size estimates from the meta-regression models for SPC, in relation to cows with no mastitis in the same time period, suggest that, on average, SPC increases by 0.46 inseminations (95% CI: 0.30, 0.62) for a cow experiencing mastitis pre-insemination leading to conception. When mastitis occurs either pre- or post-insemination leading to conception, SPC is expected to increase, on average, by 0.72 inseminations (95% CI: 0.48, 0.95) compared with cows with no mastitis in the same time period. The estimated effect sizes for FSP/AI suggest a risk ratio of conceiving at first insemination of 0.90 (95% CI: 0.82, 0.99) for cows with mastitis diagnosed pre-first insemination with respect to cows with no mastitis in the same time period, and a risk ratio of 0.79 (95% CI: 0.72, 0.86) for cows diagnosed with mastitis either pre- or post-first insemination with respect to cows with no mastitis in the same time period. Publication bias was identified in 4 of the meta-analysis models (TFS, DO, SPC, and FSCR), but no influential trials were identified in any models; the reliability of the meta-analysis results should be interpreted carefully keeping these limitations in mind. Further meta-regression analysis would be valuable as additional studies are published that report other potential sources of heterogeneity.